Michels Family Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$662K Sell
10,918
-330
-3% -$19.2K 0.48% 68
2025
Q4
$607K Buy
11,248
+190
+2% +$9.14K 0.45% 74
2025
Q3
$499K Buy
+11,058
New +$516K 0.39% 85

Other funds holding BMY

Michels Family Financial's BMY Position: Q1 2026 in Review

Michels Family Financial reduced its Bristol-Myers Squibb (BMY) stake by 2.9% in Q1 2026, selling an estimated $19.2K and leaving 10,918 shares worth $662K. The position accounts for 0.48% of the portfolio, ranked #68.

Michels Family Financial first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Michels Family Financial held 10,918 shares of Bristol-Myers Squibb worth $662K as of Q1 2026.
  • Michels Family Financial sold 330 Bristol-Myers Squibb shares in Q1 2026, an estimated $19.2K.
  • Bristol-Myers Squibb made up 0.48% of Michels Family Financial's portfolio in Q1 2026, its #68 holding.
  • Michels Family Financial first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Michels Family Financial's 13F filing for Q1 2026, filed 24 Apr 2026.